Jayakumar R. Nair

1.8k total citations
45 papers, 1.3k citations indexed

About

Jayakumar R. Nair is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Jayakumar R. Nair has authored 45 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 18 papers in Oncology and 12 papers in Hematology. Recurrent topics in Jayakumar R. Nair's work include Multiple Myeloma Research and Treatments (11 papers), PARP inhibition in cancer therapy (11 papers) and DNA Repair Mechanisms (10 papers). Jayakumar R. Nair is often cited by papers focused on Multiple Myeloma Research and Treatments (11 papers), PARP inhibition in cancer therapy (11 papers) and DNA Repair Mechanisms (10 papers). Jayakumar R. Nair collaborates with scholars based in United States, India and Italy. Jayakumar R. Nair's co-authors include Kelvin P. Lee, Louise Carlson, Lawrence Boise, Jung‐Min Lee, Asher Chanan‐Khan, Stanley Lipkowitz, Alexandra S. Zimmer, Peter Novick, Elizabeth M. Swisher and Stephen P. Schoenberger and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and The Journal of Experimental Medicine.

In The Last Decade

Jayakumar R. Nair

44 papers receiving 1.3k citations

Peers

Jayakumar R. Nair
Catherine J. Huntoon United States
Leonie Gibson Australia
Meera Nanjundan United States
Caroline Tang United States
Garry B. Udy New Zealand
Yie Liu United States
Jayakumar R. Nair
Citations per year, relative to Jayakumar R. Nair Jayakumar R. Nair (= 1×) peers Ignacio García‐Tuñón

Countries citing papers authored by Jayakumar R. Nair

Since Specialization
Citations

This map shows the geographic impact of Jayakumar R. Nair's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jayakumar R. Nair with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jayakumar R. Nair more than expected).

Fields of papers citing papers by Jayakumar R. Nair

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jayakumar R. Nair. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jayakumar R. Nair. The network helps show where Jayakumar R. Nair may publish in the future.

Co-authorship network of co-authors of Jayakumar R. Nair

This figure shows the co-authorship network connecting the top 25 collaborators of Jayakumar R. Nair. A scholar is included among the top collaborators of Jayakumar R. Nair based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jayakumar R. Nair. Jayakumar R. Nair is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Tzu‐Ting, et al.. (2024). AKT1 interacts with DHX9 to Mitigate R Loop–Induced Replication Stress in Ovarian Cancer. Cancer Research. 84(6). 887–904. 13 indexed citations
2.
Giudice, Elena, Tzu‐Ting Huang, Jayakumar R. Nair, et al.. (2024). The CHK1 inhibitor prexasertib in BRCA wild-type platinum-resistant recurrent high-grade serous ovarian carcinoma: a phase 2 trial. Nature Communications. 15(1). 2805–2805. 16 indexed citations
3.
Huang, Tzu‐Ting, Jayakumar R. Nair, Daniel An, et al.. (2023). BLM overexpression as a predictive biomarker for CHK1 inhibitor response in PARP inhibitor–resistant BRCA -mutant ovarian cancer. Science Translational Medicine. 15(701). eadd7872–eadd7872. 17 indexed citations
4.
Huang, Tzu‐Ting, Jayakumar R. Nair, Xiaohu Zhang, et al.. (2020). Targeting the PI3K/mTOR Pathway Augments CHK1 Inhibitor–Induced Replication Stress and Antitumor Activity in High-Grade Serous Ovarian Cancer. Cancer Research. 80(23). 5380–5392. 23 indexed citations
5.
Lampert, Erika J., Alexandra S. Zimmer, Michelle R. Padget, et al.. (2020). Combination of PARP Inhibitor Olaparib, and PD-L1 Inhibitor Durvalumab, in Recurrent Ovarian Cancer: a Proof-of-Concept Phase II Study. Clinical Cancer Research. 26(16). 4268–4279. 150 indexed citations
6.
Nair, Jayakumar R., Tzu‐Ting Huang, Junko Murai, et al.. (2020). Resistance to the CHK1 inhibitor prexasertib involves functionally distinct CHK1 activities in BRCA wild-type ovarian cancer. Oncogene. 39(33). 5520–5535. 30 indexed citations
7.
Lee, Jung‐Min, Jayakumar R. Nair, Alexandra S. Zimmer, et al.. (2018). Prexasertib, a cell cycle checkpoint kinase 1 and 2 inhibitor, in BRCA wild-type recurrent high-grade serous ovarian cancer: a first-in-class proof-of-concept phase 2 study. The Lancet Oncology. 19(2). 207–215. 160 indexed citations
9.
Nair, Jayakumar R., et al.. (2016). Novel inhibition of PIM2 kinase has significant anti-tumor efficacy in multiple myeloma. Leukemia. 31(8). 1715–1726. 30 indexed citations
10.
11.
Nair, Jayakumar R., et al.. (2012). Role of PI3K-Akt in crosstalk between Notch and CD28-CD80/86 pathways in dendritic cell “backsignaling” (162.2). The Journal of Immunology. 188(1_Supplement). 162.2–162.2. 1 indexed citations
12.
Nair, Jayakumar R., et al.. (2012). Under one roof. OncoImmunology. 1(3). 388–389. 15 indexed citations
13.
Arens, Ramon, Louise Carlson, Jayakumar R. Nair, et al.. (2011). Sustained antibody responses depend on CD28 function in bone marrow–resident plasma cells. The Journal of Experimental Medicine. 208(7). 1435–1446. 137 indexed citations
14.
Nair, Jayakumar R., et al.. (2008). CD28 - OLD DOG, NEW TRICKS: CD28 IN PLASMA CELL/MULTIPLE MYELOMA BIOLOGY. Advances in experimental medicine and biology. 633. 55–69. 1 indexed citations
15.
Nair, Jayakumar R. & John J. McGuire. (2005). Submitochondrial localization of the mitochondrial isoform of folylpolyglutamate synthetase in CCRF-CEM human T-lymphoblastic leukemia cells. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1746(1). 38–44. 12 indexed citations
16.
Liang, Ping, Jayakumar R. Nair, Lei Song, John J. McGuire, & Bruce J. Dolnick. (2005). Comparative genomic analysis reveals a novel mitochondrial isoform of human rTS protein and unusual phylogenetic distribution of the rTS gene. BMC Genomics. 6(1). 125–125. 7 indexed citations
17.
Nair, Jayakumar R., et al.. (2004). Cloning and partial characterization of zwittermicin A resistance gene cluster from Bacillus thuringiensis subsp. kurstaki strain HD1. Journal of Applied Microbiology. 97(3). 495–503. 13 indexed citations
18.
Nair, Jayakumar R., Gagandeep Singh, & V. Sekar. (2002). Isolation and characterization of a novel Bacillus strain from coffee phyllosphere showing antifungal activity. Journal of Applied Microbiology. 93(5). 772–780. 30 indexed citations
19.
Marrogi, Aizen J., Khan Ma, Judith A. Welsh, et al.. (2001). Oxidative Stress and p53 Mutations in the Carcinogenesis of Iron Overload-Associated Hepatocellular Carcinoma. JNCI Journal of the National Cancer Institute. 93(21). 1652–1655. 66 indexed citations
20.
Novick, Peter, et al.. (1988). Regulation of Vesicular Traffic by a GTP-binding Protein on the Cytoplasmic Surface of Secretory Vesicles in Yeast. Cold Spring Harbor Symposia on Quantitative Biology. 53(0). 637–647. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026